Since the canonical biomarkers of inflammation CRP and PCT were not informative in this study, an alternative and new infection biomarker, SuPAR (soluble urokinase plasminogen activator receptor) was evaluated, as shown in Figure 4. This evidence concerns the gene CRP and infection.